The Myeloma UK research strategy is collaborative, mission-driven and strategic in its allocation of resources and motivated by results. We have a single focus on getting the most promising new myeloma treatments to patients as quickly as possible.
Patients are at the centre of the research we fund. We focus on the needs of patients and then push that information back to accelerate clinical development and ensure creative approaches to the approval, adoption and diffusion of research results into clinical practice, for the benefit of patients.
Myeloma UK Research Programmes are designed to:
- Accelerate the testing of, and access to, new, effective treatments for myeloma to patients across the UK
- Work with patients to ensure their needs are met, and with healthcare providers to determine the future of myeloma treatment and care
- Advance the discovery and development of new treatments, with the aim of finding a cure for myeloma